Fax: (301) 402-0817
Article first published online: 19 OCT 2010
Copyright © 2010 American Cancer Society
Volume 116, Issue 23, pages 5344–5347, 1 December 2010
How to Cite
Shiels, M. S., Goedert, J. J. and Engels, E. A. (2010), Recent trends and future directions in human immunodeficiency virus-associated cancer. Cancer, 116: 5344–5347. doi: 10.1002/cncr.25705
See original referenced article on pages 5507–16, this issue.
This article is a US Government work and, as such, is in the public domain in the United States of America.
- Issue published online: 23 NOV 2010
- Article first published online: 19 OCT 2010
- Manuscript Accepted: 7 SEP 2010
- Manuscript Revised: 31 AUG 2010
- Manuscript Received: 19 JUL 2010
Malignancies, including the 3 that are part of the definition of the acquired immunodeficiency syndrome (AIDS) (Kaposi sarcoma [KS], non-Hodgkin lymphoma [NHL], and cervical cancer) as well as certain non-AIDS–defining cancers, cause significant morbidity and an estimated 33% of the deaths reported among patients infected with the human immunodeficiency virus (HIV). The US Multicenter AIDS Cohort Study (MACS) analysis highlighted several interesting and important trends in AIDS-defining and non-AIDS–defining cancers among individuals infected with HIV.